Cessatech Feed

2024-07-26 16:00:00 Cessatech: Grant of incentive warrants to Employees, CEO and the Board of Directors +2,59% | 0,08 MDKK

2024-07-05 14:36:37 Cessatech announces changes to the Board of Directors 0,00% | 0,03 MDKK

2024-07-05 14:31:18 Cessatech: Minutes of the Extraordinary General Meeting - 5 July 2024 0,00% | 0,03 MDKK

2024-06-28 12:10:26 Cessatech presents new data on paediatric pain relief at the PAGE conference in Rome favouring its lead candidate CT001 +2,95% | 0,13 MDKK

2024-06-20 16:00:00 Cessatech: EXTRAORDINARY GENERAL MEETING -2,91% | 0,11 MDKK

2024-06-03 13:00:00 Cessatech announces superior simulated pain efficacy in children favouring its lead candidate CT001 relative to its active comparators. +4,35% | 0,22 MDKK

2024-05-27 14:53:40 Cessatech reports first patient dosed in final Safety Study 0202 of lead product candidate CT001 +2,68% | 0,11 MDKK

2024-05-15 08:45:00 Cessatech: First Quarter Report Q1-2024 -4,50% | 0,11 MDKK

2024-04-18 10:46:55 Cessatech: A short business update +3,28% | 0,15 MDKK

2024-03-27 11:00:00 Minutes from the Annual General Meeting in Cessatech A/S +3,51% | 0,22 MDKK

2024-03-11 17:00:00 Cessatech: Annual General Meeting - 27 March 2024 0,00%

2024-02-29 09:00:00 Cessatech A/S publishes Annual Report for the fiscal year 2023 -5,08% | 0,19 MDKK

2024-01-30 08:30:00 Cessatech: CESSATECH ANNOUNCES RESULT OF WARRANT EXERCISE FOR WARRANTS OF SERIES TO2 +3,62% | 0,03 MDKK

2024-01-23 17:41:19 Cessatech: Correction: LAST DAY OF TRADING IN WARRANTS OF SERIES TO2 IN CESSATECH IS TOMORROW, JANUARY 24, 2024 +0,33% | 0,26 MDKK

2024-01-23 17:02:17 Cessatech: LAST DAY OF TRADING IN WARRANTS OF SERIES TO2 IN CESSATECH IS TOMORROW, JANUARY 24, 2024 -3,53% | 0,25 MDKK

2024-01-22 08:30:00 Cessatech: CESSATECH ANNOUNCES THAT MANAGEMENT AND BOARD HAVE EXERCISED ALL THEIR WARRANTS OF SERIES TO2 +1,30% | 0,23 MDKK

2024-01-12 08:00:00 Cessatech: CESSATECH ANNOUNCES THE START OF THE EXERCISE PERIOD FOR WARRANTS OF SERIES TO2 -0,30% | 0,72 MDKK

2024-01-11 08:00:00 Cessatech: CESSATECH ANNOUNCES TO2 WARRANT EXERCISE PRICE AND START OF EXERCISE PERIOD -5,98% | 0,49 MDKK

2024-01-04 17:30:00 Cessatech: Q&A session related topline data Study 0205 +4,83% | 0,30 MDKK

2023-11-16 08:30:00 Cessatech: Third Quarter Report Q3-2023 -4,22% | 0,14 MDKK

2023-10-25 08:00:00 Cessatech announces that the Paediatric Committee has agreed to a 50% reduction of the required number of patients in the final study of its nasal spray for the treatment of acute pain in children +6,90% | 0,12 MDKK

2023-09-21 13:55:51 Cessatech announces last participant dosed in pivotal trial 0205 with lead candidate CT001 -1,96% | 0,10 MDKK

2023-09-12 08:45:00 Cessatech announces agreement with the European Medicines Agency on a Paediatric Investigational Plan for its second asset CT002 for medical procedural sedation in children +21,95% | 1,01 MDKK

2023-08-24 17:30:00 Cessatech: Second quarter report Q2-2023 +5,00% | 0,01 MDKK

2023-08-17 17:30:00 Cessatech secures DKK 5 million loan facility agreement to support the US launch of its lead program CT001 -1,30% | 0,00 MDKK

2023-06-30 08:58:43 Cessatech - Ventis Pharma US partnership - Q&A +5,28% | 0,03 MDKK

2023-06-27 07:50:00 Cessatech and Ventis Pharma announce US partnership for CT001 +3,66% | 0,26 MDKK

2023-05-31 08:30:00 Cessatech provides positive news regarding shelf life of CT001 -2,31% | 0,04 MDKK

2023-05-12 08:00:00 Cessatech: First quarter report Q1-2023 -6,54% | 0,04 MDKK

2023-04-19 10:43:29 Cessatech: April business update - the business strategy -3,23% | 0,02 MDKK

2023-03-23 14:00:00 Minutes from the Annual General Meeting in Cessatech A/S +8,61% | 0,01 MDKK

2023-03-23 14:00:00 Cessatech announces new Chairman of the Board +8,61% | 0,01 MDKK

2023-03-08 17:00:00 Cessatech: Annual General Meeting - 23 March 2023 +6,38% | 0,02 MDKK

2023-02-28 16:30:00 Cessatech A/S publishes Annual Report for the fiscal year 2022 -0,94% | 0,00 MDKK

2023-01-27 07:30:00 Cessatech: Welcome to 2023 and our January business update... 0,00% | 0,07 MDKK

2023-01-17 17:30:00 Cessatech: Grant of incentive warrants to Employees, CEO and the Board of Directors -4,90% | 0,09 MDKK

2022-12-07 16:00:00 Cessatech: CESSATECH'S COMPENSATION ISSUE IN CONNECTION WITH THE RECENT RIGHTS ISSUE HAS BEEN REGISTERED -0,52% | 0,02 MDKK

2022-11-24 17:00:00 Cessatech: CESSATECH'S BOARD RESOLVES ON COMPENSATION ISSUE IN CONNECTION WITH THE RECENT RIGHTS ISSUE -0,26% | 0,10 MDKK

2022-11-18 16:45:09 Cessatech: CESSATECH ANNOUNCES LAST DAY OF TRADING IN BTU AND THE FIRST DAY OF TRADING IN WARRANTS OF SERIES TO2 +4,37% | 0,04 MDKK

2022-11-18 08:30:00 Cessatech: Third quarter report Q3-2022 +4,37% | 0,04 MDKK

2022-11-14 14:06:21 Cessatech: CESSATECH ANNOUNCES OUTCOME OF RIGHTS ISSUE -5,36% | 0,12 MDKK

2022-11-08 11:18:59 Cessatech: TOMORROW IS THE LAST DAY OF THE SUBSCRIPTION PERIOD IN CESSATECH'S RIGHTS ISSUE +3,38% | 0,04 MDKK

2022-11-04 10:21:48 Cessatech: Minutes of the Extraordinary general meeting +7,02% | 0,10 MDKK

2022-10-27 17:30:00 Cessatech: THE SUBSCRIPTION PERIOD HAS STARTED IN CESSATECH'S RIGHTS ISSUE +9,32% | 0,02 MDKK

2022-10-20 18:00:00 Cessatech: Extraordinary general meeting -9,80% | 0,07 MDKK

2022-10-20 08:30:00 Cessatech: CESSATECH PUBLISHES OFFERING MEMORANDUM IN CONNECTION WITH 80% GUARANTEED RIGHTS ISSUE -46,54% | 0,48 MDKK

2022-10-19 18:00:00 Cessatech: CESSATECH ANNOUNCES DKK 18.3 MILLION CAPITAL RAISE THROUGH A 80% GUARANTEED RIGHTS ISSUE TO FINANCE PIVOTAL DEVELOPMENT OF CT001 -46,54% | 0,48 MDKK

2022-10-10 17:00:00 Cessatech: Great progress during Q3 - more to come -1,41% | 0,03 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Cessatech

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden